KELLEY BRANT: Open Payments
NPI 1912641390 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,565 in 78 payments from 6 companies in 2025. Trend: 2023 $305 · 2024 $12,234 · 2025 $27,565
Speaker / faculty: $9,845Consulting: $7,399Travel & lodging: $6,821Food & beverage: $3,500
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 59 | $20,348 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $6,872 |
| GENZYME CORPORATION | 2 | $248 |
| Verona Pharma, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
Products named: TYVASO, DUPIXENT, STEEN SOLUTION, Ohtuvayre, TEZSPIRE, ULTOMIRIS.
Industry payments across UT — which companies pay providers there.
